[HTML][HTML] Angiosarcoma: a review of diagnosis and current treatment

J Cao, J Wang, C He, M Fang - American journal of cancer …, 2019 - ncbi.nlm.nih.gov
Angiosarcoma is a highly malignancy of endothelial tumor and represents 1-2% of all soft
tissue sarcomas in humans. The aetiology of angiosarcoma is not clear but there are definite …

Cutaneous angiosarcoma: a current update

E Shustef, V Kazlouskaya, VG Prieto, D Ivan… - Journal of Clinical …, 2017 - jcp.bmj.com
Cutaneous angiosarcoma (cAS) is a rare malignant neoplasm with variable clinical
presentation. Although a distinct vascular tumour, cAS shares many overlap** …

Primary and secondary breast angiosarcoma: single center report and a meta-analysis

Y Abdou, A Elkhanany, K Attwood, W Ji… - Breast Cancer Research …, 2019 - Springer
Background Primary and secondary breast angiosarcoma is a rare and aggressive
malignancy with limited published literature. Optimal management is mostly based on expert …

Histopathologic grading is of prognostic significance in primary angiosarcoma of breast: proposal of a simplified 2-tier grading system

MG Kuba, JK Dermawan, B Xu, S Singer… - The American journal …, 2023 - journals.lww.com
Despite a wide spectrum of clinical presentations, including primary or secondary, most
angiosarcomas are considered high grade. One exception is primary breast angiosarcoma …

[HTML][HTML] Kaposi sarcoma and cutaneous angiosarcoma: guidelines for diagnosis and treatment

C Requena, M Alsina, D Morgado-Carrasco… - Actas Dermo …, 2018 - Elsevier
Kaposi sarcoma is a vascular sarcoma with 4 clinical variants: classic Kaposi sarcoma,
which mainly affect the extremities of elderly patients and follows a chronic, generally …

DNA methylation profiling identifies distinct clusters in angiosarcomas

ME Weidema, E van de Geer, C Koelsche… - Clinical Cancer …, 2020 - AACR
Purpose: DNA methylation profiling has previously uncovered biologically and clinically
meaningful subgroups within many tumor types, but was not yet performed in angiosarcoma …

Clinical and molecular insights of radiation-induced breast sarcomas: is there hope on the horizon for effective treatment of this aggressive disease?

S Kokkali, JD Moreno, J Klijanienko… - International Journal of …, 2022 - mdpi.com
Radiation-induced breast sarcomas (RIBS) are rare entities representing< 1% of all primary
breast malignancies, limiting most reports to small retrospective case series. They constitute …

Immunohistochemistry in the Diagnosis and Classification of Breast Tumors

H Sun, Q Ding, AA Sahin - Archives of Pathology & …, 2023 - meridian.allenpress.com
Context.—In the clinical practice of breast pathology, immunohistochemistry (IHC) of
different markers is widely used for the diagnosis and classification of breast lesions …

Radiation and the immune system: current knowledge and future perspectives

K Lumniczky, SM Candéias, US Gaipl… - Frontiers in …, 2018 - frontiersin.org
At present, the opinions about the interaction between ionizing radiation and the immune
system are largely controversial. For long, high-dose ionizing radiation was considered as …

[HTML][HTML] MYC amplification in angiosarcoma depends on etiological/clinical subgroups–Diagnostic and prognostic value

AG Hogeboom-Gimeno, SG van Ravensteijn… - Annals of diagnostic …, 2023 - Elsevier
Angiosarcomas (AS) are rare and heterogeneous malignant vascular tumors with a dismal
prognosis. We undertook a retrospective study of AS cases with the intent of elucidating the …